E&Venture Partners

E&Venture Partners is a venture capital firm based in Seoul, South Korea, specializing in early-stage investments in the biotech and information technology sectors. Established in 2018, the firm operates as the venture capital arm of Easy Bio, aiming to support and accelerate the growth of innovative startups within these industries.

The firm's investment strategy centers on identifying and nurturing promising startups in the biotech and IT sectors, providing them with the necessary resources and expertise to scale their operations. E&Venture Partners focuses on early-stage investments, including Series A and Series B funding rounds, to support companies in their formative years.

E&Venture Partners has demonstrated a commitment to fostering innovation and entrepreneurship in South Korea's biotech and IT sectors. Their portfolio includes investments in companies such as BIORCHESTRA, a biopharmaceutical firm that raised $45 million in a Series C funding round on February 22, 2022. This investment reflects the firm's dedication to supporting the growth of high-potential startups in these critical industries.